You are here:

doripenem (Doribax)

Marketing Authorisation Withdrawn

On 31 July 2014, the European Commission issued a decision to withdraw the marketing authorisation for Doribax, following its receipt of a letter dated 6 July 2014 notifying the Commission of the MAH’s decision to voluntarily withdraw the marketing authorisation for this product for commercial reasons. Please see link to European Medicines Agency statement.

Drug Details

Drug Name: doripenem (Doribax)
SMC Drug ID: 529/09
Manufacturer: Janssen-Cilag Ltd
Indication: Complicated intra-abdominal infections
BNF Category:
Submission Type: Full submission
Status: Marketing Authorisation Withdrawn
Date Advice Published: 9 February 2009

Extra Notes

On 31 July 2014, the European Commission issued a decision to withdraw the marketing authorisation for Doribax, following its receipt of a letter dated 6 July 2014 notifying the Commission of the MAH’s decision to voluntarily withdraw the marketing authorisation for this product for commercial reasons.  

Back